Pasithea Therapeutics Corp. (KTTA)
NASDAQ·Healthcare·Biotechnology
$0.51
-0.21%
Mkt Cap $5.95M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+484.8%
Consensus $3.00 vs current $0.51
NASDAQ·Healthcare·Biotechnology
$0.51
-0.21%
Mkt Cap $5.95M
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+484.8%
Consensus $3.00 vs current $0.51